Comparison of two vaginal cream Artemisia and clotrimazole in treatment of vaginal candidiasis

Not Applicable

• Conditions: vulvovaginit candidiasis.; Vulvovaginal ulceration and inflammation in diseases classified elsewhere; n77.1*

• Registration Number: IRCT2016121831454N1
• Lead Sponsor: Mashhad University of Medical Sciences - Deputy of Research and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

signs and symptoms of Candida vaginitis? positive culture and wet smear of vaginal discharge. Exclusion criteria: pregnancy? hypersensitivity to clotrimasol or artemisia? recurrent Candida vaginitis (4 or more Candida vaginitis in a year)? consumption of immunosuppressive drugs or systemic antibiotics? history of diabetes? using vaginal creams 2 weeks prior to the study? consumption of systemic anti-fungal drugs during 2 weeks prior to the study? presence of non-candidia vaginitis? consumption of oral contraceptives.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Discharge. Timepoint: Baseline, 1 week+_24 hours after treatment. Method of measurement: Clinical Examination, observation, and medical history.

Secondary Outcome Measures

Name	Time	Method
Pruritus. Timepoint: Baseline, 1 week+_24hours after treatment. Method of measurement: History.;Erythema symptoma. Timepoint: Baseline, 1 week _+24 hours after treatment. Method of measurement: Observation, and History.;Dysuria. Timepoint: Baseline, 1 week+_24 hours after treatment. Method of measurement: History.;Dysparonia Symptom. Timepoint: Baseline, 1 week+_ 24hours after treatment. Method of measurement: History.;Vaginal Culture. Timepoint: Baseline, 1 week+_24 hours after treatment. Method of measurement: Vaginal Culture.